Enlivex Therapeutics Ltd. Annual Earnings Per Share, Basic in USD/shares from 2020 to 2023

Taxonomy & unit
us-gaap: USD/shares
Description
The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.
Summary
Enlivex Therapeutics Ltd. quarterly/annual Earnings Per Share, Basic history and growth rate from 2020 to 2023.
  • Enlivex Therapeutics Ltd. Earnings Per Share, Basic for the quarter ending June 30, 2024 was -0.16 USD/shares, a 56.8% increase year-over-year.
  • Enlivex Therapeutics Ltd. annual Earnings Per Share, Basic for 2023 was -1.56 USD/shares, a 7.69% increase from 2022.
  • Enlivex Therapeutics Ltd. annual Earnings Per Share, Basic for 2022 was -1.69 USD/shares, a 109% decline from 2021.
  • Enlivex Therapeutics Ltd. annual Earnings Per Share, Basic for 2021 was -0.81 USD/shares, a 10% increase from 2020.
Earnings Per Share, Basic, Annual (USD/shares)
Earnings Per Share, Basic, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 -$2 +$0.13 +7.69% Jan 1, 2023 Dec 31, 2023 20-F 2024-04-30
2022 -$2 -$1 -109% Jan 1, 2022 Dec 31, 2022 20-F 2024-04-30
2021 -$1 +$0.09 +10% Jan 1, 2021 Dec 31, 2021 20-F 2024-04-30
2020 -$1 Jan 1, 2020 Dec 31, 2020 20-F 2023-04-10
* An asterisk sign (*) next to the value indicates that the value is likely invalid.